Gapping down
In reaction to earnings/guidance:
- TPX -8.3%, UIS -4.5%, HLX -4%, ETRN -2.4%, CFX -0.9%, HD -0.3%
Other news:
- FIXX -32.1% (provides update on pheNIX gene therapy trial of HMI-102 in adults with PKU; trial placed on clinical hold)
- KPTI -24.6% (announces departure of Jatin Shah, M.D., as Chief Medical Officer)
- RSX -12.8% (tensions escalate in Russia/Ukraine)
- ADGI -8.1% (announced a Chief Executive Officer succession plan; outlines strategic initiatives for ADG20 program)
- VWE -3.9% (announces voluntary delisting from TSX, effective at the close on March 7)
- VIVO -2.2% (appoints Andy Kitzmiller as CFO)
- RNG -2% (RingCentral and Zoom (ZM) settle litigation)
- ZM -1.4% (RingCentral and Zoom (ZM) settle litigation)
- CARR -1.1% (updates its medium term outlook)
Analyst comments:
- CRNC -5.4% (downgraded to Neutral from Buy at Goldman)
- DKNG -5.1% (downgraded to Equal Weight from Overweight at Wells Fargo)
- GT -2.9% (downgraded to Hold from Buy at Williams Trading)
- CE -1.9% (downgraded to Underweight from Neutral at Piper Sandler)